Access cutting-edge dipg treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access dipg specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related dipg treatment provided free
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type2.0/2.1 in combination with Doxorubicin therapy for the treatment of DIPG in pediatric patients
Sponsor: InSightec
Check if you qualify for this dipg clinical trial in Washington Dc, DC
If you're searching for dipg treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dipg specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.